Ethics approval and consent to participate
Tumor tissue samples (self-blood negative control) of pan-cancer were
subjected to NGS n a College of American Pathologists (CAP) and Clinical
Laboratory Improvement Amendments (CLIA) certified laboratory of 3D
Medicines Inc. This study was conducted under the approval of the ethics
committees of the hospitals and informed consents were obtained from
patients.